Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

FALCON''S BEYOND GLOBAL, INC. (FBYD)

  • Business News
  • Aug. 13, 2026, 11:45 UTC
  • 2
  • 1 comments

Falcon’s Beyond Reports Second Quarter 2026 Financial Results

Market reaction Comment Full text

AMERICAN SHARED HOSPITAL SERVICES (AMS)

  • Business News
  • Aug. 13, 2026, 11:40 UTC
  • 2
  • 1 comments

Form 8.3

Market reaction Comment Full text

WONG FONG INDUSTRIES LTD (1A1)

  • Business News
  • Aug. 13, 2026, 11:37 UTC
  • 2
  • 1 comments

Financial Statements and Related Announcement: Half Yearly Results

Market reaction Comment Full text

Auxly Cannabis Group Inc. (CBWTF)

  • Business News
  • Aug. 13, 2026, 11:36 UTC
  • 2
  • 1 comments

Auxly Reports Second Quarter 2026 Results

Market reaction Comment Full text

CLEARMIND MEDICINE INC. (CMND)

  • Business News
  • Aug. 13, 2026, 11:36 UTC
  • 2
  • 1 comments

Clearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint

Market reaction Comment Full text

MEMIONTEC HOLDINGS LTD. (TWL)

  • Business News
  • Aug. 13, 2026, 11:35 UTC
  • 2
  • 1 comments

Financial Statements and Related Announcement: Half Yearly Results

Market reaction Comment Full text

MEMIONTEC HOLDINGS LTD. (TWL)

  • Business News
  • Aug. 13, 2026, 11:35 UTC
  • 2
  • 1 comments

Interested Person Transaction: Interested Person Transaction pursuant to Catalist Rule 905(2)

Market reaction Comment Full text

ADVANCED FLOWER CAPITAL INC. (AFCG)

  • Business News
  • Aug. 13, 2026, 11:33 UTC
  • 2
  • 1 comments

AFC Announces Financial Results for the Second Quarter 2026

Market reaction Comment Full text

IREN LTD (IREN)

  • Business News
  • Aug. 13, 2026, 11:33 UTC
  • 2
  • 1 comments

IREN Delivers Horizon 1 to Microsoft and Achieves NVIDIA Exemplar Cloud Status on GB300 NVL72

Market reaction Comment Full text

Karyopharm Therapeutics Inc (KPTI)

  • Business News
  • Aug. 13, 2026, 11:32 UTC
  • 2
  • 1 comments

Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission

Market reaction Comment Full text
  • Previous
  • 1586
  • 1587
  • 1588
  • 1589
  • 1590
  • Next

Search

News categories

  • Technical Exchange News(14737)
  • Event(6229)
  • SEC News(396137)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(241537)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin